COGT
Cogent Biosciences·NASDAQ
--
--(--)
--
--(--)
COGT fundamentals
Cogent Biosciences (COGT) released its earnings on Nov 3, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.5 (YoY +21.88%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.5
+21.88%
Report date
Nov 3, 2025
EPS
Actual | -0.8 | -0.96 | -5.07 | -6.06 | -0.34 | -0.43 | -0.48 | -0.6 | -0.68 | -0.71 | -0.5 | -0.56 | -0.54 | -0.59 | -0.64 | -0.63 | -0.62 | -0.59 | -0.64 | -0.61 | -0.6353 | -0.53 | -0.5 | ||||||||
Forecast | -1.2 | -0.84 | -0.56 | -0.51 | -0.415 | -0.3567 | -0.45 | -0.524 | -0.605 | -0.6567 | -0.5133 | -0.5171 | -0.5713 | -0.5444 | -0.5011 | -0.5634 | -0.5145 | -0.557 | -0.5662 | -0.6085 | -0.5928 | -0.587 | -0.5165 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +33.33% | -14.29% | -805.36% | -1088.24% | +18.07% | -20.55% | -6.67% | -14.50% | -12.40% | -8.12% | +2.59% | -8.30% | +5.48% | -8.38% | -27.72% | -11.82% | -20.51% | -5.92% | -13.03% | -0.25% | -7.17% | +9.71% | +3.19% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 7.03M | 528.00K | 312.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 2.00M | 0 | 0 | 50.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +251.55% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Cogent Biosciences next quarter?What is Cogent Biosciences's gross profit margin?What is Cogent Biosciences's latest dividend and current dividend yield?What were the key takeaways from Cogent Biosciences's earnings call?What is the revenue and EPS growth rate for Cogent Biosciences year over year?Did Cogent Biosciences beat or miss consensus estimates last quarter?What does Cogent Biosciences do and what are its main business segments?What guidance did Cogent Biosciences's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
